✦ LIBER ✦

PND20 COST-UTILITY ANALYSIS EVALUATING THE LIDOCAINE 5% MEDICATED PLASTER RELATIVE TO GABAPENTIN AND PREGABALIN FOR POST-HERPETIC NEURALGIA IN GERMANY

✍ Scribed by H Liedgens; N Hertel; A Gabriel; MJC Nuijten; HA Dakin; U Spöhrer; B Poulsen Nautrup

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

568 COST-UTILITY ANALYSIS EVALUATING THE

✍ V. Mayoral; J.M. Collar; H. Liedgens; M.J.C. Nuijten 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

PND13 COST-EFFECTIVENESS ANALYSIS OF THE

✍ H Liedgens; N Hertel; A Gabriel; MJC Nuijten; HA Dakin; U Spöhrer; B Poulsen Nau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

NE4 COST-UTILITY ANALYSIS EVALUATING LID

✍ HA Dakin; MJC Nuijten; H Liedgens; B Poulsen Nautrup 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PND7 COST-EFFECTIVENESS OF A LIDOCAINE P

✍ MJ Nuijten; BR Pais; H Liedgens; AJ van Wijck 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB